(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUESTS:
Bloomberg healthcare reporter Cynthia Koons on Pfizer buying eczema drugmaker Anacor for $5.2 billion.

John Kilduff, Founding partner of Again Capital, on the oil markets, and the rally:  is the global supply glut really over?
 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUESTS: Bloomberg healthcare reporter Cynthia Koons on Pfizer buying eczema drugmaker Anacor for $5.2 billion. John Kilduff, Founding partner of Again Capital, on the oil markets, and the rally: is the global supply glut really over? Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Bloomberg's Koons on Pfizer, Again's Kilduff on Oil  (Audio)

Matt Miller and Paul Sweeney focus on market coverage as Wall Street begins its day, with analysis from Bloomberg Opinion writers, Bloomberg Intelligence analysts, and influential newsmakers.

Share Bloomberg's Koons on Pfizer, Again's Kilduff on Oil (Audio)

Sign up to save your podcasts

Bloomberg's Koons on Pfizer, Again's Kilduff on Oil (Audio)

Bloomberg's Koons on Pfizer, Again's Kilduff on Oil (Audio)